Review Article
Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future
Table 2
HIV drug approval/authorization dates.
| Drug | Canada (Health Canada) | US (FDA) | Europe (EMEA) |
| Enfuvirtide | July 14, 2003 | March 13, 2003 | May 5, 2003 | Tipranavir | November 21, 2005 | June 22, 2005 | October 25, 2005 | Darunavir | July 28, 2006 | June 23, 2006 | February 12, 2007 | Maraviroc | September 21, 2007 | August 6, 2007 | September 18, 2007 | Raltegravir | November 27, 2007 | October 12, 2007 | December 20, 2007 | Etravirine | August 23, 2008 | January 18, 2008 | August 28, 2008 |
|
|
US (FDA): United States Food and Drug Administration; EMEA: European Medicines Agency.
|